Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the influenza diagnostic market right now?

There has been substantial growth in the influenza diagnostic market size in recent years. An expansion from $2.73 billion in 2024 to $2.89 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.9%, is anticipated. The growth experienced in the historic period is largely due to the boost in e-commerce, labor shortages, automation and productivity, optimization of supply chains, increasing labor costs, and government backing for automation and robotics.

How fast Is the influenza diagnostic market expected to grow, and what’s its future value?

Expectations are high for significant expansion in the influenza diagnostic market in the upcoming years. With a compound annual growth rate (CAGR) of 8.5%, the market is anticipated to reach $4.01 billion in 2029. Factors contributing to this predicted growth during the forecast period include the need for customization and scalability, environmental and sustainability targets, efficiency enhancement requirements, and the necessity to conform to the demands of contemporary supply chain dynamics. The forecast period is also likely to witness key trends such as integration of cutting-edge technology, robot-assisted picking and packing, autonomous mobile robots, on-the-spot data and analytics, AI-powered decision making, cooperative robots, and progress in robotic technology.

Get your influenza diagnostic market report here!

https://www.thebusinessresearchcompany.com/sample.aspx?id=3237&type=smp

What are the leading drivers of growth in the influenza diagnostic market?

The influenza diagnostic market is projected to be propelled forward by the rise of rapid diagnostic tests. These medical tools or procedures are used to establish or dispel the presence of a condition or disease. With an increasing demand for quick and accurate outcomes in healthcare, Rapid diagnostic tests (RDTs) are on the rise. Rapid influenza diagnostic tests (RIDTs) are capable of identifying influenza viral antigens within 10-15 minutes with a moderate sensitivity of 50-70%. For example, the Australian Institute of Health and Welfare, an Australian government agency that focuses on health and disease information, reported in July 2024 that diagnostic imaging services had increased from 28.4 million in 2021-22 to 29.7 million in 2022-23. Therefore, rapid diagnostic tests are playing a significant part in the expansion of the influenza diagnostic market.

What are the key segments defining the influenza diagnostic market?

The influenza diagnostic market covered in this report is segmented –

1) By Traditional diagnostic tests: Rapid influenza diagnostic tests (RIDT), Viral Culture, DFA, Serological assays, Other Traditional diagnostic tests

2) By Molecular diagnostic tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests

3) By End User: Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users

Subsegments:

1) By Rapid Influenza Diagnostic Tests (RIDT): Immunoassay-based Tests, Lateral Flow Assays, Enzyme Immunoassays (EIA)

2) By Viral Culture: Cell Culture, Egg-based Culture

3) By Direct Fluorescent Antibody (DFA) Test: Direct Fluorescent Antibody Staining

4) By Serological Assays: Hemagglutination Inhibition (HI) Assay, Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting Assay

5) By Other Traditional Diagnostic Tests: Polymerase Chain Reaction (PCR), Immunofluorescence Assays

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3237&type=smp

Who are the key players steering the development of the influenza diagnostic market?

Major companies operating in the influenza diagnostic market include F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton Dickinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMérieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., Labcorp Employer Services Inc., TotalWellness Ltd., Health Advocate Inc., Optum Global Solutions Private Ltd.

What emerging trends are influencing the growth of the influenza diagnostic market?

In the influenza diagnostic market, prominent businesses are introducing state-of-the-art products like the Lucira COVID-19 & Flu Home Test, designed for quick qualitative detection. Its application involves a single-use at-home test kit, providing results from self-obtained nasal swabs in roughly half an hour. An example is Pfizer Inc., a pharmaceutical corporation based in the United States, which secured approval for the Lucira COVID-19 & Flu Home Test in February 2023. This test can identify both influenza A and B, usually referred to as the flu, and SARS-CoV-2, which is the virus causing COVID-19.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3237

Which regions are most influential in expanding the influenza diagnostic market?

North America was the largest region in the influenza diagnostics market in 2023. Western Europe was the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Immunofluorescence Assay Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/immunofluorescence-assay-global-market-report

Diagnostic Enzyme Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/diagnostic-enzymes-global-market-report

Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/isothermal-nucleic-acid-amplification-technology-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: